Product
Etripamil NS
Aliases
Etripamil NS 70 mg
3 clinical trials
3 indications
Indication
TachycardiaIndication
Supraventricular tachycardiaIndication
Paroxysmal Supraventricular TachycardiaClinical trial
Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia in Chinese PatientsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
An Open Label Extension Study of Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular TachycardiaStatus: , Estimated PCD: 2025-04-01
Clinical trial
Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia The NODE-302 Trial (Extension of NODE-301)Status: Terminated, Estimated PCD: 2020-11-13